CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 161 enrolled
Drug / intervention
Intravenous ibuprofen +1 moredrug
Likely dose
Intravenous ibuprofen 10mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01332253
NCT01332253Phase 3Completed

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Trial of the Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy

Cumberland Pharmaceuticals·interventional·Posted Apr 11, 2011·Updated Nov 3, 2016

In Brief

A Phase 3 clinical trial evaluating Intravenous ibuprofen and Normal Saline for Tonsillectomy. Completed, enrolled 161 participants across 6 sites.

Detailed Summary

The hypothesis is that a single, pre-operative dose of intravenous ibuprofen will significantly reduce post-operative fentanyl use compared to placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTonsillectomy
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 11, 2011
Enrollment StartJul 1, 2011
Primary CompletionJul 1, 2012
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 15.2 years ago

Interventions

Intravenous ibuprofendrug

Participants will receive a single 10mg/kg dose of intravenous ibuprofen diluted in normal saline at the induction of anesthesia.

Normal Salineother

Participants will receive a comparable weight based volume of normal saline as a placebo comparator at the induction of anesthesia.